Search
for

    Did you mean Monoclonal Antibodies?
    Glossary Monoclonal Antibodies

    laboratory-produced molecules that target specific cells or proteins

    Monoclonal antibodies (mAbs) are laboratory-produced molecules engineered to serve as substitute antibodies that can restore, enhance, or mimic the immune system's attack on cells. They are designed to bind to specific targets, such as proteins on the surface of cancer cells, making them useful in treating various diseases, including some types of cancer, autoimmune disorders, and infectious diseases.

    Related Terms

    Research

    5 / 1000+ results

      research ANTI‐HAIR KERATIN MONOCLONAL ANTIBODY (HKN‐2)

      13 citations , August 1985 in “The Journal of Dermatology”
      This study identified a monoclonal antibody, HKN-2, that recognizes specific cells in human skin and may indicate a common antigenic determinant between hair and other skin epithelial tissues.

      research Generation of Pax1/PAX1-Specific Monoclonal Antibodies

      10 citations , October 2016 in “Monoclonal antibodies in immunodiagnosis and immunotherapy”
      This study developed rat monoclonal antibodies that specifically detect Pax1/PAX1 protein, which could improve diagnostic protocols for conditions involving deregulated Pax1/PAX1 expression.

      research Anti‐keratin Monoclonal Antibody against Basal Cell Epithelioma Keratin: BKN‐1

      8 citations , August 1987 in “The Journal of Dermatology”
      This study reports that the monoclonal antibody BKN-1 specifically stained basal cell epithelioma cells and certain normal skin structures, indicating a similarity in keratin expression between the tumor and follicular epithelium below the isthmus portion.

    Learn

    1 / 800 results

      learn HMI-115

      much-hyped research compound targeting prolactin receptor in scalp
      • What is HMI-115 and how is it different from common treatments like minoxidil? HMI-115 (BAY 1158061) is an investigational monoclonal antibody that blocks the prolactin receptor, not a GnRH antagonist. It is given by injection in trials and is not approved anywhere; minoxidil is an approved topical vasodilator with decades of published data, while HMI-115's hair-loss trial results remain unpublished.

    Community Join

    5 / 11 results

      community Why hasn’t anyone made a "DHT sponge" biologic yet???

      in Research/Science  45 upvotes 10 months ago
      The conversation discusses the potential for developing a biologic "DHT sponge" to neutralize DHT in the bloodstream as a treatment for hair loss, suggesting it could be more targeted and have fewer side effects than current treatments like finasteride and dutasteride. Concerns include the complexity, cost, and potential side effects of such a treatment, as well as skepticism about its feasibility and market interest.

      community Prolactin the Cause of Hair Loss? ABS-201 the Cure?

       29 upvotes 2 months ago
      Prolactin may contribute to hair loss, but targeting its receptor won't cure androgenetic alopecia. ABS-201 could be a useful alternative or adjuvant therapy, similar to JAK inhibitors, but not more effective than HMI-115.

      community Any news on potential hair loss treatments?

       11 upvotes 2 years ago
      The conversation is about seeking updates on new hair loss treatments, specifically mentioning scube3 and GT20029, with one person mentioning HMI_115 as showing promising results.

      community Androgen degraders for hair loss

       61 upvotes 2 years ago
      The conversation discusses androgen receptor degraders for hair loss, highlighting their potential advantages over traditional AR blockers like RU58841 and pyrilutamide. Concerns about the safety and cost of these treatments are also mentioned.